by Jason Heaviland | Jul 23, 2026
How Genomics and Exposomics Will Transform Precision Medicine Genomics has transformed precision medicine by revealing an individual’s genetic blueprint—but genetics alone cannot explain why people with similar genomes often experience very different health...
by Jason Heaviland | Jul 22, 2026
How Exposomics Can Improve Clinical Trials and Precision Medicine Why do promising drugs fail in Phase III clinical trials? Why do patients respond differently to the same therapy across countries? And if genetics only explains part of disease risk, what information...
by Jason Heaviland | Jul 16, 2026
How are exposure patterns linked to biological pathways? Environmental chemical exposures can significantly influence drug metabolism, therapeutic response, and disease biology—but they are often overlooked in biomedical research and clinical development.In this...
by ODWAdmin | Mar 6, 2024
Using Metabolomics to Study Responders and Non-Responders Welcome to Panome Bio’s ChatGJP series with CSO Gary J. Patti, Ph.D. In this session, we ask Dr. Patti, “How is metabolomics being used to identify responder and non-responder populations in clinical...
